RxDoctor Payments Data

Theresa Oakley, DO

General Practice · Apopka, FLNPI 1093735805

Payments from drug & device makers

$879in general payments, 2019–2025

Across 40 payments — averaging $21.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$320
  • Lilly USA, LLC$266
  • Novo Nordisk$89
  • Amgen$47
  • Abbott$38
  • Pfizer$34
  • plus $86 from 4 others

What the payments were for

  • Food & beverage$879100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$879 in reported general payments places this provider in the 75th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$194,092
Medicare patients
254
Services billed
3,709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban55$91,307
OzempicSemaglutide47$72,035
TrulicityDulaglutide43$55,744
MounjaroTirzepatide24$42,993
JardianceEmpagliflozin24$21,371
XareltoRivaroxaban11$16,930
SynthroidLevothyroxine Sodium61$7,429
Breo ElliptaFluticasone/Vilanterol14$7,293
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$6,048
Rosuvastatin Calcium373$4,090
Atorvastatin Calcium416$3,450
Albuterol Sulfate HfaAlbuterol Sulfate66$3,304
Mesalamine DrMesalamine11$2,779
Levothyroxine Sodium244$2,307
Losartan Potassium190$1,881

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$266$98,73767 claims
PfizerEliquis$34$91,30755 claims
Novo NordiskOzempic$89$72,03547 claims
AbbVieSynthroid$320$7,42961 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,901 general practice providers in Florida.

Other general practice in Apopka

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →